Rejected Compounds. (a) Compounds which the Joint Research Committee determines meet Research Target Profile but which are not accepted by ZENECA for development as Development Candidates will continue to be owned in their entirety by ISIS. [ * ]
Appears in 2 contracts
Samples: Research and Development Agreement, Research and Development Agreement (Isis Pharmaceuticals Inc)
Rejected Compounds. (a) Compounds which the Joint Research Committee determines meet Research Target Profile but which are not accepted by ZENECA for development as Development Candidates will continue to be owned in their entirety by ISIS. [ * ]However, ISIS will not have the right to develop, commercialize or sublicense any such Compounds for so long as ZENECA has an Active Target Program for the Target for such Compound.
Appears in 2 contracts
Samples: Research and Development Agreement, Research and Development Agreement (Isis Pharmaceuticals Inc)